Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Suliman, Sara"'
Autor:
Suliman S; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Sara.Suliman@ucsf.edu i.vanrhijn@uu.nl.; Division of Experimental Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA., Kjer-Nielsen L; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Iwany SK; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Lopez Tamara K; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Socios en Salud Sucursal Perú, Lima, Peru., Loh L; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO., Grzelak L; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Kedzierska K; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Ocampo TA; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Corbett AJ; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., McCluskey J; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Rossjohn J; Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., León SR; Socios en Salud Sucursal Perú, Lima, Peru., Calderon R; Socios en Salud Sucursal Perú, Lima, Peru., Lecca-Garcia L; Socios en Salud Sucursal Perú, Lima, Peru., Murray MB; Department of Global Health and Social Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Division of Global Health Equity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and., Moody DB; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Van Rhijn I; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Sara.Suliman@ucsf.edu i.vanrhijn@uu.nl.; Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 Mar 15; Vol. 208 (6), pp. 1389-1395. Date of Electronic Publication: 2022 Mar 04.
Autor:
Gela A; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Murphy M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Rodo M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa., Hadley K; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Hanekom WA; Africa Health Research Institute, KwaZulu-Natal, South Africa., Boom WH; Tuberculosis Research Unit, Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Johnson JL; Tuberculosis Research Unit, Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Hoft DF; Division of Infectious Diseases, Allergy & Immunology, Edward A. Doisy Research Center, Saint Louis University School of Medicine, St. Louis, MO, USA., Joosten SA; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., Suliman S; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Moody DB; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Lewinsohn DM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Seshadri C; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA., Nemes E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa. Electronic address: thomas.scriba@uct.ac.za., Briel L; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Veldtsman H; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Khomba N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Pienaar B; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Africa H; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Steyn M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Publikováno v:
EBioMedicine [EBioMedicine] 2022 Feb; Vol. 76, pp. 103839. Date of Electronic Publication: 2022 Feb 08.
Autor:
Suliman S; Division of Rheumatology, Immunity and Inflammation, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Gela A; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Iwany SK; Division of Rheumatology, Immunity and Inflammation, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Tamara KL; Division of Rheumatology, Immunity and Inflammation, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Socios En Salud Sucursal Peru, Lima, Peru., Mabwe S; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Bilek N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Darboe F; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Fisher M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Corbett AJ; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Kjer-Nielsen L; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Eckle SBG; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Huang CC; Department of Global Health and Social Medicine, and Division of Global Health Equity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Zhang Z; Department of Global Health and Social Medicine, and Division of Global Health Equity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Lewinsohn DM; Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland VA Medical Center, Portland, Oregon, USA., McCluskey J; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Rossjohn J; Infection and Immunity Program and The Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria, Australia.; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom., Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., León SR; Socios En Salud Sucursal Peru, Lima, Peru., Calderon RI; Socios En Salud Sucursal Peru, Lima, Peru., Lecca L; Socios En Salud Sucursal Peru, Lima, Peru.; Department of Global Health and Social Medicine, and Division of Global Health Equity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Murray M; Department of Global Health and Social Medicine, and Division of Global Health Equity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Van Rhijn I; Division of Rheumatology, Immunity and Inflammation, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands., Moody DB; Division of Rheumatology, Immunity and Inflammation, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2020 Aug 17; Vol. 222 (6), pp. 995-1007.
Autor:
Suliman S; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa; ssuliman1@bwh.harvard.edu.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115., Murphy M; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Musvosvi M; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Gela A; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Meermeier EW; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239., Geldenhuys H; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Hopley C; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Toefy A; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Bilek N; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Veldsman A; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Hanekom WA; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Johnson JL; Tuberculosis Research Unit, Case Western Reserve University School of Medicine, Cleveland, OH 44106.; Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, Cleveland, OH 44106., Boom WH; Tuberculosis Research Unit, Case Western Reserve University School of Medicine, Cleveland, OH 44106.; Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, Cleveland, OH 44106., Obermoser G; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305; and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305., Huang H; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305; and.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305., Hatherill M; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Lewinsohn DM; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239., Nemes E; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2019 Dec 01; Vol. 203 (11), pp. 2917-2927. Date of Electronic Publication: 2019 Oct 14.
Autor:
Suliman, Sara, Kjer-Nielsen, Lars, Iwany, Sarah K., Tamara, Kattya Lopez, Loh, Liyen, Grzelak, Ludivine, Kedzierska, Katherine, Ocampo, Tonatiuh A., Corbett, Alexandra J., McCluskey, James, Rossjohn, Jamie, León, Segundo R, Calderon, Roger, Lecca-Garcia, Leonid, Murray, Megan B., Moody, D. Branch, Van Rhijn, Ildiko
Publikováno v:
J Immunol
Mucosal-associated invariant T (MAIT) cells are innate-like T cells that are highly abundant in human blood and tissues. Most MAIT cells have an invariant T cell receptor (TCR) α chain that uses TRAV1–2 joined to TRAJ33/20/12 and recognize metabol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8660e75d8172216f316496e35a992e7
https://europepmc.org/articles/PMC9359468/
https://europepmc.org/articles/PMC9359468/
Autor:
Suliman, Sara, Kjer-Nielsen, Lars, Iwany, Sarah K, Lopez Tamara, Kattya, Loh, Liyen, Grzelak, Ludivine, Kedzierska, Katherine, Ocampo, Tonatiuh A, Corbett, Alexandra J, McCluskey, James, Rossjohn, Jamie, León, Segundo R, Calderon, Roger, Lecca-Garcia, Leonid, Murray, Megan B, Moody, D Branch, Van Rhijn, Ildiko, Immunologie, dI&I RA-I&I I&I
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950), vol 208, iss 6
Journal of Immunology, 208(6), 1389. American Association of Immunologists
Journal of Immunology, 208(6), 1389. American Association of Immunologists
Mucosal-associated invariant T (MAIT) cells are innate-like T cells that are highly abundant in human blood and tissues. Most MAIT cells have an invariant TCRα-chain that uses T cell receptor α-variable 1-2 (TRAV1-2) joined to TRAJ33/20/12 and reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d55ae9d276575bf193a8b74bff490e
https://escholarship.org/uc/item/1442b6mq
https://escholarship.org/uc/item/1442b6mq